BioSpace News Archive

Biotech Bay

Ceterix Orthopaedics Awarded New Patent for Circumferential Suturing Method in Meniscus Repair

Ceterix’s new patent further protects the company’s unique products and methods that allow surgeons to arthroscopically pass suture through soft tissue in very tight joint compartments.

January 15, 2018
·
2 min read
Business

Avacta Group Plc Announces Positive Outcome of Proof-of-Concept Study With Glythera and Follow-on Drug Development Partnership

Avacta Group plc is pleased to announce that its initial study with Glythera Limited, the developer of next generation antibody drug conjugates, has concluded successfully.

January 15, 2018
·
2 min read
Avivagen Announces Positive Results From Swine Trial

Results from the independent study demonstrated that OxC-beta not only benefited sow health but also led to improvements in the health of nursing piglets.

January 15, 2018
·
6 min read
Pharm Country

Creative Peptides Added New GLP-1 Peptides for Diabetes Research

On January 11, 2018, the leading peptide expert Creative Peptides announced to add new GLP-1 peptides targeting for diabetes research.

January 15, 2018
·
2 min read
USRM Reaches Key Sales Milestone of Proprietary Adipocell Product

Adipocell, which has been developed, marketed and distributed by USRM, enables physicians to separate potent stem cells from a patient’s own fat cells.

January 15, 2018
·
4 min read
Business

MPI’s Spinout Oncology Venture Will Execute License to Multi TKI Phase III Compound

Oncology Venture has decided to execute the TKI license which has already been negotiated.

January 15, 2018
·
4 min read
Business

Cytovance Biologics Welcomes Edwin Miranda as Vice President of Quality

Edwin Miranda will be leading the full breadth of Cytovance’s Quality function.

January 15, 2018
·
1 min read
Policy

Shire Granted EU Marketing Authorization for ADYNOVI [Antihemophilic Factor (Recombinant), Pegylated] for Adults and Adolescents With Hemophilia A

Marketing Authorization will enable patient access to ADYNOVI throughout Europe.

January 15, 2018
·
13 min read
Drug Development

Tigenix Announces Publication in Gastroenterology of 52-Week Results of the Phase III ADMIRE-CD Trial of Cx601

The one-year data also confirmed the favorable safety and tolerability profile of Cx601 reported at week 24.

January 15, 2018
·
7 min read
Policy

Prevtec Microbia Receives Market Authorization from USDA for Coliprotec F4

Prevtec Microbia announce that it has received a market authorization from the Centre for Veterinary Biologics U.S. of the Department of Agriculture (USDA-CVB) to commercialize its vaccine Coliprotec® F4 in the US, a front line product against post weaning diarrhea (PWD) in pigs.

January 15, 2018
·
2 min read